Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Nov 11, 2026
TickeronGET DAILY SIGNALS
IDEV vs IDMO: Broad Core Exposure or Concentrated Momentum in Developed Markets

IDEV vs IDMO: Broad Core Exposure or Concentrated Momentum in Developed Markets

Key Takeaways

  • IDEV offers broad, market-cap-weighted exposure to roughly 2,250+ developed-market stocks outside the U.S., while IDMO is a concentrated momentum strategy holding roughly 165–195 stocks.
  • IDEV is dramatically cheaper at a 0.04% expense ratio, versus 0.25% for IDMO, a meaningful gap for long-term core holdings.
  • IDMO's momentum screen has produced heavy financial-sector concentration (often 40–50% of assets) and a single-stock position in ASML near 9%, whereas IDEV spreads risk across financials, industrials, healthcare, and technology.
  • Both funds exclude U.S. equities and serve as international diversification tools, but they target different investor goals: core index exposure versus factor-driven momentum.
  • Tickeron AI Verdict: IDEV — the broader, lower-cost, and more diversified fund is favored for durable, risk-adjusted positioning in the current environment.

Why These Two ETFs Stand Out for International Exposure

International developed-market ETFs have drawn renewed investor attention as investors look beyond a historically expensive U.S. equity market for diversification and valuation relief. These two funds — IDEV and IDMO — both provide exposure to developed markets outside the United States, yet they are built on fundamentally different foundations. IDEV is a low-cost, all-cap core index fund spanning more than two thousand companies, while IDMO is a rules-based momentum product that concentrates capital in a smaller set of recent winners. They do not compete as identical strategies; rather, they represent alternative approaches to the same broad geographic opportunity set. This ETF comparison examines their structural differences, sector exposure, cost efficiency, and relative positioning. I also checked this using Tickeron’s AI Screener to see how the funds line up against peers.

A Closer Look at IDEV

IDEV is a passively managed fund that seeks to track the MSCI World ex USA Investable Market Index, a free-float-adjusted, market-capitalization-weighted benchmark covering large-, mid-, and small-cap equities across developed markets in North America, Europe, Australasia, and the Far East. With roughly 2,250 to 2,300 holdings and an expense ratio of just 0.04%, it is among the most cost-efficient ways to own a broad international developed-market sleeve.

Sector exposure is well diversified, with financials (about 24%), industrials (about 19%), healthcare (about 9%), information technology (about 9%), materials (about 8%), and consumer discretionary (about 8%) representing the largest weights. Top holdings include ASML, HSBC, AstraZeneca, Novartis, Nestlé, Royal Bank of Canada, Siemens, Shell, and Toyota, with the top ten positions accounting for only about 10% of assets. Geographically, Japan, the United Kingdom, and Canada are the largest country exposures. This broad footprint makes IDEV a natural core building block for investors seeking inexpensive, whole-market international equity exposure.

Understanding IDMO's Momentum Approach

IDMO is a passively implemented, factor-based fund that tracks the S&P World Ex-U.S. Momentum Index. The underlying index selects large- and mid-cap stocks from developed markets outside the U.S. (and South Korea) that exhibit the strongest risk-adjusted price momentum, weighting them by momentum scaled by market capitalization. The fund holds roughly 165 to 195 securities and rebalances semi-annually, on the third Friday of March and September. Its expense ratio is 0.25%.

Because momentum screens chase recent winners, IDMO's sector allocation diverges sharply from the broad market. Financials have frequently represented 40% to 50% of the portfolio, with industrials (about 20–22%) and materials (about 10–11%) also prominent. Top holdings include ASML (near 9%), Royal Bank of Canada, HSBC, Toronto-Dominion Bank, Novartis, Mitsubishi UFJ Financial Group, TotalEnergies, and BHP Group. This concentration means IDMO behaves less like a diversified international index and more like a momentum-and-banks trade, carrying meaningfully higher single-sector and single-stock risk.

The Broader Market Context

Both funds are shaped by the broader environment for developed-market equities outside the United States. A weaker U.S. dollar, relatively attractive international valuations, and elevated exposure to cyclical sectors such as financials and industrials have supported non-U.S. equities in recent market cycles. Rising or persistently elevated interest rates have been a particular tailwind for global banks, which helps explain why financials dominate IDMO's momentum screen. At the same time, semiconductor and capital-goods names such as ASML have driven pockets of outperformance. The key risk is concentration: when leadership rotates, factor portfolios anchored to the prior trend can reverse quickly. Regulatory developments in European banking and shifting central-bank rate expectations remain important swing factors for both funds' financial-heavy exposure.

How They Stack Up in Recent Markets

In recent weeks and months, both funds have benefited from international equity strength, but their risk profiles differ materially. IDMO's momentum tilt has allowed it to capture sharp upside when financials and select industrial and technology names lead, yet its concentrated book also introduces higher volatility and tracking error relative to the broad index. IDEV, by contrast, delivers a steadier, market-like return stream spread across more than two thousand securities and multiple sectors. When sector leadership broadens or rotates, IDEV's diversification tends to smooth drawdowns, while IDMO's holdings remain tied to whichever segment has recently carried the market. For investors evaluating fund performance and relative positioning, the trade-off is straightforward: IDMO offers concentrated factor exposure with higher upside potential in momentum-friendly regimes, while IDEV offers lower-cost, lower-dispersion core exposure.

Refining ETF Choices with AI Tools

In my own research process, I frequently rely on Tickeron’s AI Screener to compare holdings, costs, and momentum signals across international ETFs. This tool helps surface patterns and relative strengths that might otherwise take hours to analyze manually, giving me a clearer view before committing capital.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IDMO, IDEV

IDMO's RSI Oscillator climbs out of oversold territory

The RSI Indicator for IDMO moved out of oversold territory on November 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 24 similar instances when the indicator left oversold territory. In 24 of the 24 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 58 of 66 cases where IDMO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.

Following a +3.46% 3-day Advance, the price is estimated to grow further. Considering data from situations where IDMO advanced for three days, in 270 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

IDMO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IDMO as a result. In 62 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.

The Moving Average Convergence Divergence Histogram (MACD) for IDMO turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 41 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDMO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for IDMO entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Industry description

The investment seeks to track the investment results (before fees and expenses) of the S&P World Ex-U.S. Momentum Index. The fund will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, the index provider compiles, maintains and calculates the underlying index, which is composed of constituents of the S&P World Ex-U.S. Index.

Market Cap

The average market capitalization across the Invesco S&P International Developed Momentum ETF (IDMO) ETF is 41.32B. The market cap for tickers in the group ranges from 10.11B to 15.52B. TSEM holds the highest valuation in this group at 15.52B. The lowest valued company is FRO at 10.11B.

High and low price notable news

The average weekly price growth across all stocks in the Invesco S&P International Developed Momentum ETF (IDMO) ETF was -1%. For the same ETF, the average monthly price growth was -5%, and the average quarterly price growth was -4%. TSEM experienced the highest price growth at -9%, while FRO experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Invesco S&P International Developed Momentum ETF (IDMO) ETF was 48%. For the same stocks of the ETF, the average monthly volume growth was 88% and the average quarterly volume growth was 6%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 63
Price Growth Rating: 51
SMR Rating: 55
Profit Risk Rating: 56
Seasonality Score: 7 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
XRPN fell -9.70% in early regular-session trading on Tuesday, sliding from Monday's $10.41 close to $9.40. The decline follows a November 9 SEC prospectus disclosing a committed equity facility with Cantor to sell up to 5.2 million new Class A shares at 97% of the volume-weighted average price, implying up to roughly 16.7% potential dilution.
The central target of $1,620 is the arithmetic mean of verified, current analyst price targets, rounded to a clean level; it is not a single firm's forecast or a guarantee. At a recent price of about $690 , reaching $1,620 would require a gain of roughly 135% , a very large move by any standard.
The $1.50 central target is a fallback objective drawn from public market and technical discussion, not an analyst consensus, because AquaBounty Technologies, Inc. (NASDAQ: AQB) has no credible, current sell-side price targets. With the stock near $0.95, reaching $1.50 would require roughly 58% upside, a very large move for a company that has wound down its core aquaculture operations.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.